Company news
Home > News > Company news
Yabao Pharmaceutical Co., Ltd. Beijing Passed US FDA Approval
2013/12/24

 Yabao Pharmaceutical Co., Ltd. Beijing Passed US FDA Approval

December 24th, 2013
 
Dec.17th, 2013, Yabao Pharmaceutical Co., Ltd. Beijing received the confirmation letter from US FDA that the solid dosage plant as well as its related quality system of Yabao Pharmaceutical Beijing is in compliance with current good manufacturing practice (cGMP) requirements. As a wholly-owned subsidiary of Yabao Pharmaceutical Group, Yabao Beijing was inspected by US FDA in site on Aug.12-16, 2013.
The site approval by US FDA for the solid dosage plant in Yabao Beijing is just a starting point for Yabao to invest more in building a robust quality system and a global-standard research and development platform. Yabao is concentrating on the researching and developing for the innovative new drug and generics in speciality as well as its manufacturing and distributing in China as well as the counties with the regulatory approvals.